Subtype
Skin Basal Cell Carcinoma
CI-CAN-00003940BCCExplore in graph →
17 active trials1 approved drugs
Loading cancer entity…
Subtype
CI-CAN-00003940BCCExplore in graph →
Clinical trials
83 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (4)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02699723 | Arsenic Trioxide and Itraconazole in Treating Patients With Advanced Basal Cell Cancer | withdrawn | Early Phase 1 | 0 | Jean Yuh TangOTHER | 0 | Oct 22, 2020 | clinicaltrials |
| NCT02507076 | Isolated Limb Perfusion With Melphalan in Treating Patients With Stage IIIB-IV Melanoma or Sarcoma | withdrawn | N/A | 0 | Albert Einstein College of MedicineOTHER | 1 | Jul 23, 2015 | clinicaltrials |
Showing 1–2 of 2 studies
Data updated 22 days agoSource updated Oct 22, 2020source: clinicaltrials